← Open Payments lookup

THOMAS WIND: Open Payments

NPI 1508982265 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,659 in 146 payments from 20 companies in 2025. Trend: 2023 $3,747 · 2024 $2,921 · 2025 $2,659

Food & beverage: $2,659
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$546
ABBVIE INC.27$333
Axsome Therapeutics, Inc.16$249
Collegium Pharmaceutical, Inc.12$221
Neurocrine BioSciences, Inc.10$210
Vanda Pharmaceuticals Inc.10$171
E.R. Squibb & Sons, L.L.C.1$114
Janssen Pharmaceuticals, Inc5$110
Teva Pharmaceuticals USA, Inc.4$86
Alkermes, Inc.4$82

Products named: CAPLYTA, VRAYLAR, Auvelity, Jornay PM, INGREZZA, FANAPT, REXULTI, COBENFY.

Industry payments across PA — which companies pay providers there.